Clinical outcome analysis of 98 elderly women with early-stage breast cancer undergoing modified radical mastectomy or simple mastectomy

2012 ◽  
Vol 11 (7) ◽  
pp. 403-406
Author(s):  
Zhilong Jia ◽  
Baoxia Su
Keyword(s):  
Breast Cancer ◽  
Clinical Outcome ◽  
Elderly Women ◽  
Early Stage ◽  
Radical Mastectomy ◽  
Early Stage Breast Cancer ◽  
Outcome Analysis ◽  
Modified Radical Mastectomy ◽  
Simple Mastectomy

Costs of Treatment for Elderly Women With Early-Stage Breast Cancer in Fee-for-Service Settings

2002 ◽  
Vol 20 (1) ◽  
pp. 307-316 ◽  
Author(s):  
Joan L. Warren ◽  
Martin L. Brown ◽  
Michael P. Fay ◽  
Nicola Schussler ◽  
Arnold L. Potosky ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Terminal Care ◽  
Elderly Women ◽  
Early Stage ◽  
Radical Mastectomy ◽  
Cancer Registries ◽  
Early Stage Breast Cancer ◽  
Fee For Service ◽  
Initial Care

PURPOSE: This study provides population-based estimates of the treatment costs for elderly women with early-stage breast cancer, with emphasis on costs of modified radical mastectomy (MRM) compared with breast-conserving surgery (BCS) and radiation therapy (RT). PATIENTS AND METHODS: Women with breast cancer from the Surveillance, Epidemiology, and End Results cancer registries were linked with their Medicare claims, 1990 through 1998. Each claim was assigned to an initial, continuing, or terminal care phase after a cancer diagnosis. Mean monthly phase-specific costs were determined for all health care and for treatment related only to cancer. Cumulative long-term costs of care that accrue during a women’s remaining lifetime were calculated by treatment group. RESULTS: Initial care costs for the 6 months after diagnosis for women who underwent BCS with RT were approximately $450 per month higher than for women with MRM. During the continuing-care phase, costs for women undergoing BCS with RT were significantly less expensive than for MRM cases. The two groups had similar costs in the terminal-care phase. Assuming the same survival distributions, long-term costs for women undergoing BCS with RT were not statistically different than for women undergoing MRM. CONCLUSION: Although mastectomy was less costly in the initial phase, the lifetime costs of BCS with RT and mastectomy were equivalent. Thus, women’s preferences, resources to cover out-of-pocket costs, and life situations should be the major factors addressed in shared decision making about treatment options.

scholarly journals Trends in Surgical Axillary Management in Early Stage Breast Cancer in Elderly Women: Continued Over-Treatment

2020 ◽  
Vol 27 (9) ◽  
pp. 3426-3433 ◽  
Author(s):  
Raphael J. Louie ◽  
Charles E. Gaber ◽  
Paula D. Strassle ◽  
Kristalyn K. Gallagher ◽  
Stephanie M. Downs-Canner ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Elderly Women ◽  
Early Stage ◽  
Early Stage Breast Cancer

Impact of Her-2 Neu Overexpression on Outcome of Elderly Women Treated With Wide Local Excision and Breast Irradiation for Early Stage Breast Cancer

2006 ◽  
Vol 29 (1) ◽  
pp. 71-79 ◽  
Author(s):  
Igor M. Poltinnikov ◽  
Shari B. Rudoler ◽  
Yevgen Tymofyeyev ◽  
Julia Kennedy ◽  
Pramila R. Anne ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Local Excision ◽  
Wide Local Excision ◽  
Elderly Women ◽  
Early Stage ◽  
Early Stage Breast Cancer ◽  
Breast Irradiation ◽  
Her 2

The role of radiotherapy in elderly women with early-stage breast cancer treated with breast conserving surgery

2018 ◽  
Vol 104 (6) ◽  
pp. 429-433 ◽  
Author(s):  
Mariacarla Valli ◽  
Simona Cima ◽  
Paola Fanti ◽  
Barbara Muoio ◽  
Alessandra Vanetti ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Overall Survival ◽  
Elderly Women ◽  
Early Stage ◽  
Conservative Surgery ◽  
Early Stage Breast Cancer ◽  
Axillary Lymph Nodes ◽  
Axillary Lymph ◽  
Significant Difference ◽  
The Impact

Objective: To analyze the impact of adjuvant radiotherapy (RT) on ipsilateral breast recurrence (IBR) and overall survival (OS) in patients older than 69 years with early-stage breast cancer. Methods: From January 2007 to June 2015, we analyzed retrospectively 137 women with estrogen receptor–positive T1–2 invasive breast cancer, with negative axillary lymph nodes, dividing them into 2 subgroups: 70 to 79 years and older than 79 years. Results: After a median follow-up of 43.2 months, the 3-year IBR-free survival in patients treated with surgery plus RT was 98.8% and 92.1% in patients treated with surgery alone, with a significant difference ( p = .01). Radiotherapy did not impact overall survival ( p = .10). A higher percentage of patients aged between 70 and 79 years received RT after conservative surgery if compared with the older subgroup ( p < .01). Conclusions: In elderly women, adjuvant RT reduced the IBR, but did not improve OS.

Sign in / Sign up

Export Citation Format

Share Document